Poirel Laurent, Jayol Aurélie, Nordmann Patrice
Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland
French INSERM European Unit, University of Fribourg (LEA-IAME), Fribourg, Switzerland.
Clin Microbiol Rev. 2017 Apr;30(2):557-596. doi: 10.1128/CMR.00064-16.
Polymyxins are well-established antibiotics that have recently regained significant interest as a consequence of the increasing incidence of infections due to multidrug-resistant Gram-negative bacteria. Colistin and polymyxin B are being seriously reconsidered as last-resort antibiotics in many areas where multidrug resistance is observed in clinical medicine. In parallel, the heavy use of polymyxins in veterinary medicine is currently being reconsidered due to increased reports of polymyxin-resistant bacteria. Susceptibility testing is challenging with polymyxins, and currently available techniques are presented here. Genotypic and phenotypic methods that provide relevant information for diagnostic laboratories are presented. This review also presents recent works in relation to recently identified mechanisms of polymyxin resistance, including chromosomally encoded resistance traits as well as the recently identified plasmid-encoded polymyxin resistance determinant MCR-1. Epidemiological features summarizing the current knowledge in that field are presented.
多粘菌素是公认的抗生素,由于耐多药革兰氏阴性菌引起的感染发病率不断上升,最近重新引起了人们的极大关注。在临床医学中观察到多药耐药性的许多地区,黏菌素和多粘菌素B正被重新认真考虑作为最后的抗生素选择。与此同时,由于多粘菌素耐药菌的报告增多,目前正在重新考虑在兽医学中大量使用多粘菌素的情况。多粘菌素的药敏试验具有挑战性,本文介绍了目前可用的技术。介绍了为诊断实验室提供相关信息的基因型和表型方法。本综述还介绍了与最近发现的多粘菌素耐药机制相关的最新研究成果,包括染色体编码的耐药特征以及最近发现的质粒编码的多粘菌素耐药决定因子MCR-1。本文还介绍了总结该领域当前知识的流行病学特征。